輸入代號或公司名稱後按 Enter
8432

東生華

+0.20 (+0.40%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
50.109成交張數11.47本益比1.35股價淨值比5.23%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入20251,337年增 +19.8%
毛利率202550.9%最新一期
營業利益率202516.3%最新一期
每股盈餘20253.63年增 +23.1%
會計項目走勢20162017201820192020202120222023202420252026 預估 1 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計34.8%34.7%35.2%38.0%36.3%40.2%39.7%50.7%47.8%49.1%
營業毛利(毛損)65.2%65.3%64.8%62.0%63.7%59.8%60.3%49.3%52.2%50.9%51.2%
營業毛利(毛損)淨額65.2%65.3%64.8%62.0%63.7%59.8%60.3%49.3%52.2%50.9%
推銷費用23.6%23.9%23.5%28.1%27.9%29.1%30.1%26.6%22.4%24.0%
管理費用11.8%11.5%11.7%12.4%12.8%11.6%10.9%12.0%12.1%8.7%
研究發展費用23.5%15.3%18.8%10.4%6.4%5.7%5.7%3.1%2.5%1.8%
預期信用減損損失(利益)-1.1%0.0%-0.0%-0.0%0.0%-0.2%0.1%0.1%
營業費用合計58.9%50.7%52.8%50.9%47.1%46.4%46.7%41.5%37.0%34.6%
營業利益(損失)6.3%14.6%12.0%11.1%16.6%13.5%13.6%7.8%15.2%16.3%17.4%
利息收入0.5%0.5%0.7%0.8%0.5%0.6%
其他收入1.0%0.8%0.6%0.6%0.0%0.0%0.0%0.1%0.2%0.2%
其他利益及損失淨額24.9%-0.1%0.1%8.7%0.1%0.9%2.3%0.7%-0.3%0.5%
財務成本淨額0.0%0.0%0.0%0.0%0.1%0.0%0.1%
營業外收入及支出合計25.9%0.7%0.8%9.3%0.7%1.4%3.0%1.5%0.3%1.2%
稅前淨利(淨損)32.2%15.2%12.8%20.4%17.2%14.9%16.6%9.4%15.5%17.6%
所得稅費用(利益)合計3.5%1.9%1.6%3.6%3.5%3.5%3.3%1.4%3.5%3.5%
繼續營業單位本期淨利(淨損)28.7%13.4%11.2%16.8%13.7%11.4%13.3%8.0%12.0%14.1%
本期淨利(淨損)28.7%13.4%11.2%16.8%13.7%11.4%13.3%8.0%12.0%14.1%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.6%-3.9%2.0%-5.1%-4.4%4.9%19.7%-0.5%
與不重分類之項目相關之所得稅-0.6%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
不重分類至損益之項目:-3.9%2.0%-5.1%-4.4%4.9%19.7%-0.5%
國外營運機構財務報表換算之兌換差額0.0%0.0%0.0%0.0%-0.0%0.0%0.0%
後續可能重分類至損益之項目:0.0%0.0%0.0%0.0%-0.0%0.0%0.0%
其他綜合損益(淨額)5.5%-51.3%-0.6%-3.9%2.0%-5.1%-4.4%4.9%19.7%-0.5%
本期綜合損益總額34.2%-38.0%10.6%12.9%15.7%6.3%8.9%12.9%31.8%13.5%
母公司業主(淨利∕損)7.6%10.1%10.4%10.6%
非控制權益(淨利∕損)-0.0%1.9%3.6%
母公司業主(綜合損益)12.6%29.9%9.9%
非控制權益(綜合損益)-0.0%1.9%3.6%
基本每股盈餘0.7%0.3%0.3%0.4%0.4%0.3%0.3%0.2%0.3%0.3%0.3%
稀釋每股盈餘0.7%0.3%0.3%0.4%0.4%0.3%0.3%0.2%0.3%0.3%
透過其他綜合損益按公允價值衡量之債務工具投資未實現評價損益-0.6%0.0%0.0%0.0%0.0%0.0%0.0%
共同控制下前手權益(淨利∕損)0.4%0.0%
共同控制下前手權益(綜合損益)0.4%0.0%
備供出售金融資產未實現評價損益5.5%-51.3%0.0%
採用權益法認列之關聯企業及合資損益之份額淨額0.0%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。